Texas Set to Invest $50 Million Into Psychedelic Research at State University

Former FDA scientist and psychedelics researcher hired as CDER deputy director

The FDA is bringing back Michael Davis as the next deputy director of the Center for Drug Evaluation and Research, according to an internal memo viewed by Endpoints News. Davis’ hiring comes a day after ...

Texas Commits $50M to Ibogaine Research for PTSD and Brain Injury

Texas allocates $50M for ibogaine research at a state university to study its potential in treating addiction, PTSD, and brain injury.

Texas set to invest $50 million into psychedelic research at state university

Gov. Greg Abbott signed Senate Bill 2308 into law on June 11, which designates $50 million to research ibogaine, a psychedelic that could be used to treat addiction, traumatic brain injuries and post-traumatic stress.  The Texas Health and Human Services Commission will select a consortium that consists of a state university, drug developer and hospital to research the psychedelic, according to the bill. Greg Fonzo, co-director of the UT Charmai…